Treatment of Extraneural Metastases of Myxopapillary Ependymomas With Dose-Dense Temozolomide and Lapatinib

Devon C Riegel1, Ekokobe Fonkem1, Jennifer M Connelly1

  • 1Neurology, Medical College of Wisconsin, Milwaukee, USA.

Cureus
|August 28, 2024
PubMed

Insights

This case study details a rare instance of myxopapillary ependymoma (MPE) extraneural metastasis. The patient showed a mixed radiographic response to dose-dense TMZ and lapatinib, offering new treatment insights.

Area of Science:

  • Neuro-oncology
  • Pathology

Background:

  • Myxopapillary ependymomas (MPEs) are rare central nervous system tumors.
  • Recurrent MPEs have poorer prognoses, and extraneural metastasis is exceptionally uncommon.